Priscilla Cascetta

503 total citations
15 papers, 368 citations indexed

About

Priscilla Cascetta is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Priscilla Cascetta has authored 15 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Priscilla Cascetta's work include Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (6 papers) and Renal cell carcinoma treatment (4 papers). Priscilla Cascetta is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Cancer Genomics and Diagnostics (6 papers) and Renal cell carcinoma treatment (4 papers). Priscilla Cascetta collaborates with scholars based in Italy, France and United Kingdom. Priscilla Cascetta's co-authors include Roberto Bianco, Luigi Formisano, Paola Ciciola, Cataldo Bianco, Alessandro Morabito, Nicola Normanno, David Planchard, Vincenzo Sforza, Anna Manzo and Giovanna Esposito and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Priscilla Cascetta

15 papers receiving 361 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Priscilla Cascetta Italy 10 234 142 135 84 57 15 368
Tae‐You Kim South Korea 9 194 0.8× 182 1.3× 121 0.9× 82 1.0× 37 0.6× 10 402
Kate Young United Kingdom 11 240 1.0× 92 0.6× 115 0.9× 45 0.5× 64 1.1× 30 365
Lingzhi Hong United States 12 216 0.9× 213 1.5× 238 1.8× 115 1.4× 37 0.6× 28 487
Monica Capozzi Italy 11 239 1.0× 133 0.9× 72 0.5× 94 1.1× 122 2.1× 22 434
Marco Brugia Italy 12 218 0.9× 117 0.8× 128 0.9× 100 1.2× 27 0.5× 31 354
Anna Manzo Italy 10 248 1.1× 164 1.2× 170 1.3× 73 0.9× 82 1.4× 25 398
Jianling Zou China 14 243 1.0× 200 1.4× 119 0.9× 122 1.5× 24 0.4× 18 467
Guo Long China 13 170 0.7× 213 1.5× 152 1.1× 165 2.0× 94 1.6× 26 492
Rebecca Tay United Kingdom 11 412 1.8× 88 0.6× 211 1.6× 61 0.7× 58 1.0× 22 512
Ki Sun Jung South Korea 10 146 0.6× 201 1.4× 153 1.1× 82 1.0× 25 0.4× 21 347

Countries citing papers authored by Priscilla Cascetta

Since Specialization
Citations

This map shows the geographic impact of Priscilla Cascetta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Priscilla Cascetta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Priscilla Cascetta more than expected).

Fields of papers citing papers by Priscilla Cascetta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Priscilla Cascetta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Priscilla Cascetta. The network helps show where Priscilla Cascetta may publish in the future.

Co-authorship network of co-authors of Priscilla Cascetta

This figure shows the co-authorship network connecting the top 25 collaborators of Priscilla Cascetta. A scholar is included among the top collaborators of Priscilla Cascetta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Priscilla Cascetta. Priscilla Cascetta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Citarella, Fabrizio, Kazuki Takada, Priscilla Cascetta, et al.. (2024). Clinical implications of the family history in patients with lung cancer: a systematic review of the literature and a new cross-sectional/prospective study design (FAHIC: lung). Journal of Translational Medicine. 22(1). 714–714. 3 indexed citations
2.
Cascetta, Priscilla, Anna Reni, Francesco Facchinetti, et al.. (2023). Discontinuation of immunotherapy over 2 years for patients with non–small cell lung cancer (NSCLC): A search for predictors.. Journal of Clinical Oncology. 41(16_suppl). 2661–2661. 1 indexed citations
3.
Servetto, Alberto, Antonio Santaniello, Fabiana Napolitano, et al.. (2022). FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine in Metastatic Pancreatic Adenocarcinoma: An Observational Study. Future Oncology. 18(21). 2643–2653. 2 indexed citations
4.
Riudavets, Mariona, Priscilla Cascetta, & David Planchard. (2022). Targeting BRAF-mutant non-small cell lung cancer: Current status and future directions. Lung Cancer. 169. 102–114. 15 indexed citations
5.
Sforza, Vincenzo, Giuliano Palumbo, Priscilla Cascetta, et al.. (2022). BRAF Inhibitors in Non-Small Cell Lung Cancer. Cancers. 14(19). 4863–4863. 21 indexed citations
6.
Cascetta, Priscilla, Chiara Lazzari, Vanesa Gregorc, et al.. (2022). KRAS in NSCLC: State of the Art and Future Perspectives. Cancers. 14(21). 5430–5430. 44 indexed citations
7.
Servetto, Alberto, Antonio Santaniello, Fabiana Napolitano, et al.. (2021). Use of FOLFIRINOX or Nab-Paclitaxel Plus Gemcitabine for the Treatment of Locally Advanced Pancreatic Adenocarcinoma: A Single Institution Observational Study. Cancers. 13(19). 4939–4939. 3 indexed citations
8.
Montanino, Agnese, Anna Manzo, Guido Carillio, et al.. (2021). Angiogenesis Inhibitors in Small Cell Lung Cancer. Frontiers in Oncology. 11. 655316–655316. 53 indexed citations
9.
Cascetta, Priscilla, Vincenzo Sforza, Anna Manzo, et al.. (2021). RET Inhibitors in Non-Small-Cell Lung Cancer. Cancers. 13(17). 4415–4415. 48 indexed citations
10.
Napolitano, Fabiana, Alberto Servetto, Roberta Marciano, et al.. (2020). FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules. Therapeutic Advances in Medical Oncology. 12. 3863563010–3863563010. 10 indexed citations
11.
Ciciola, Paola, Priscilla Cascetta, Cataldo Bianco, Luigi Formisano, & Roberto Bianco. (2020). Combining Immune Checkpoint Inhibitors with Anti-Angiogenic Agents. Journal of Clinical Medicine. 9(3). 675–675. 76 indexed citations
12.
Napolitano, Fabiana, Luigi Formisano, Alessandro Giardino, et al.. (2019). Neoadjuvant Treatment in Locally Advanced Pancreatic Cancer (LAPC) Patients with FOLFIRINOX or Gemcitabine NabPaclitaxel: A Single-Center Experience and a Literature Review. Cancers. 11(7). 981–981. 35 indexed citations
13.
Formisano, Luigi, Roberta Marciano, Anna Chiara Carratù, et al.. (2019). FOLFIRINOX after first-line gemcitabine-based chemotherapy in metastatic pancreatic cancer: a mono-institutional experience. Annals of Oncology. 30. iv52–iv53. 1 indexed citations
14.
Cascetta, Priscilla, Alessandro Cavaliere, Geny Piro, et al.. (2018). Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance. International Journal of Molecular Sciences. 19(11). 3331–3331. 40 indexed citations
15.
Raimondo, Lucia, Valentina Damato, Alberto Servetto, et al.. (2016). Everolimus induces Met inactivation by disrupting the FKBP12/Met complex. Oncotarget. 7(26). 40073–40084. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tae‐You Kim Breakdown of academic impact, for papers by Kate Young Breakdown of academic impact, for papers by Lingzhi Hong Breakdown of academic impact, for papers by Monica Capozzi Breakdown of academic impact, for papers by Marco Brugia Breakdown of academic impact, for papers by Anna Manzo Breakdown of academic impact, for papers by Jianling Zou Breakdown of academic impact, for papers by Guo Long Breakdown of academic impact, for papers by Rebecca Tay Breakdown of academic impact, for papers by Ki Sun Jung
Rankless by CCL
2026